Page last updated: 2024-08-16

moxonidine and angiotensin ii

moxonidine has been researched along with angiotensin ii in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (33.33)	18.2507
2000's	2 (66.67)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
da Silva, DC; de Andrade, CA; De Luca, LA; Haikel, L; Menani, JV; Renzi, A; Sato, MA; Vieira, AA	1
Amann, K; Bielenberg, GW; Ehmke, H; Gross, ML; Koch, A; Mall, G; Oberhauser, V; Orth, SR; Ritz, E; Rump, LC; Simonaviciene, A; VAN Kats, JP; Wessels, S	1
Kotanko, P	1

Reviews

1 review(s) available for moxonidine and angiotensin ii

Article	Year
Cause and consequences of sympathetic hyperactivity in chronic kidney disease. Blood purification, 2006, Volume: 24, Issue:1 Topics: Adrenergic alpha-Agonists; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Arginine; Brain Stem; Humans; Hyperkinesis; Hypertension, Renal; Imidazoles; Kidney Failure, Chronic; Nitric Oxide Synthase; Oxazoles; Receptor, Angiotensin, Type 1; Renal Dialysis; Rilmenidine; Sympathetic Nervous System; Sympatholytics	2006

Article

Year

Cause and consequences of sympathetic hyperactivity in chronic kidney disease.

Blood purification, 2006, Volume: 24, Issue:1

Topics: Adrenergic alpha-Agonists; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Arginine; Brain Stem; Humans; Hyperkinesis; Hypertension, Renal; Imidazoles; Kidney Failure, Chronic; Nitric Oxide Synthase; Oxazoles; Receptor, Angiotensin, Type 1; Renal Dialysis; Rilmenidine; Sympathetic Nervous System; Sympatholytics

2006

Other Studies

2 other study(ies) available for moxonidine and angiotensin ii

Article	Year
Central moxonidine on water and NaCl intake. Brain research bulletin, 1999, Jul-01, Volume: 49, Issue:4 Topics: Adrenergic alpha-Antagonists; Angiotensin II; Animals; Antihypertensive Agents; Carbachol; Cholinergic Agonists; Drinking; Idazoxan; Imidazoles; Injections, Intraventricular; Male; Rats; Rats, Sprague-Dawley; Sodium Chloride, Dietary; Time Factors; Vasoconstrictor Agents	1999
Effects of low dose sympathetic inhibition on glomerulosclerosis and albuminuria in subtotally nephrectomized rats. Journal of the American Society of Nephrology : JASN, 2000, Volume: 11, Issue:8 Topics: Albuminuria; Angiotensin II; Animals; Antihypertensive Agents; Glomerulosclerosis, Focal Segmental; Imidazoles; Immunohistochemistry; In Situ Hybridization; Kidney; Male; Nephrectomy; Neural Inhibition; Norepinephrine; Proliferating Cell Nuclear Antigen; Rats; Rats, Sprague-Dawley; Reference Values; RNA, Messenger; Sympathetic Nervous System; Transforming Growth Factor beta	2000

Article

Year

Central moxonidine on water and NaCl intake.

Brain research bulletin, 1999, Jul-01, Volume: 49, Issue:4

Topics: Adrenergic alpha-Antagonists; Angiotensin II; Animals; Antihypertensive Agents; Carbachol; Cholinergic Agonists; Drinking; Idazoxan; Imidazoles; Injections, Intraventricular; Male; Rats; Rats, Sprague-Dawley; Sodium Chloride, Dietary; Time Factors; Vasoconstrictor Agents

1999

Effects of low dose sympathetic inhibition on glomerulosclerosis and albuminuria in subtotally nephrectomized rats.

Journal of the American Society of Nephrology : JASN, 2000, Volume: 11, Issue:8

Topics: Albuminuria; Angiotensin II; Animals; Antihypertensive Agents; Glomerulosclerosis, Focal Segmental; Imidazoles; Immunohistochemistry; In Situ Hybridization; Kidney; Male; Nephrectomy; Neural Inhibition; Norepinephrine; Proliferating Cell Nuclear Antigen; Rats; Rats, Sprague-Dawley; Reference Values; RNA, Messenger; Sympathetic Nervous System; Transforming Growth Factor beta

2000